Tandem Diabetes Care (TNDM) PT Raised to $24 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TNDM Hot Sheet
Price: $17.65 --0%
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Stifel analyst Matthew Blackman raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $24.00 (from $17.00) while maintaining a Hold rating.
You May Also Be Interested In
- Apollo Global Management (APO) PT Lowered to $130 at Keefe, Bruyette & Woods
- Arista Networks (ANET) PT Raised to $261; Piper Sandler Reiterates 'Top Pick'
- Keurig Dr Pepper (KDP) PT Raised to $35 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
